This meeting is the FSHD Community’s forum to present testimony by patients and family caregivers and educate the FDA on how FSHD has impacted your life or the life of your loved ones. Your input will result in a Voice of the Patient Report that will be submitted to the FDA’s Division of Neurology Products, Office of New Drugs, for inclusion in the framework used to evaluate future FSHD therapies. Your views carry great weight with the agency when it considers whether to approve a new therapy.
We encourage everyone—patients and family members, at every stage of disease progression—to get involved. You can attend via the free, live webcast on April 21st. A limited number of spaces are available for in-person attendees in Hyattsville, Maryland.
Registration required for both the webcast and in-person attendance. SPACE IS LIMITED. Click here.